2-(3,5-Dibromo-4-hydroxyphenyl)imidazo [4,5-f][1,10] phenanthrolinoruthenium(II) complexes: Synthesis, characterization, cytotoxicity, apoptosis, DNA-binding and antioxidant activity

BioMetals

Volumn 23, Issue 4, 2010, Pages 739-752

  Liu, Yun Jun ^a   Liang, Zhen Hua ^a   Li, Zheng Zheng ^a   Zeng, Cheng Hui ^a   Yao, Jun Hua ^b   Huang, Hong Liang ^a   Wu, Fu Hai ^a  

^a GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Antioxidant activity; Apoptosis; Cytotoxicity; DNA; Ruthenium(II) complexes

Indexed keywords

2 (3,5 DIBROMO 4 HYDROXYPHENYL)IMIDAZO[4,5 F][1,10]PHENANTHROLINORUTHENIUM; ACRIDINE ORANGE; DNA; ETHIDIUM BROMIDE; HYDROXYL RADICAL; RUTHENIUM COMPLEX; SINGLET OXYGEN; SUPEROXIDE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL ASSAY; CONTROLLED STUDY; CYTOCHEMISTRY; CYTOTOXICITY; DENATURATION; DNA BINDING; DNA CLEAVAGE; DRUG DNA INTERACTION; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; INTERCALATION COMPLEX; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOTOACTIVATION; PROTEIN CLEAVAGE; VISCOSITY;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CATTLE; CELL LINE; DNA; DNA CLEAVAGE; LIGANDS; MOLECULAR STRUCTURE; NUCLEIC ACID DENATURATION; PHENANTHROLINES; RUTHENIUM COMPOUNDS; VISCOSITY;

EID: 77956546130     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10534-010-9340-2     Document Type: Article

References (52)

1. Arockiasamy DL, Radhika S, Parthasarathi R, Nair BU 2009 Synthesis and DNA-binding studies of two ruthenium (II) complexes of an intercalating ligand. Eur J Med Chem 44:2044-2051. doi:10.1016/j.ejmech.2008.10.013
2. Barton JK, Raphael AL 1984 Photoactivated stereospecific cleavage of double-helical DNA by cobalt (III) complexes. JAmChem Soc 106:2466-2468. doi:10.1021/ja00320a058
3. Carter MT, Rodriguez M, Bard A 1989 Voltammetric studies of the interaction of metal chelates with DNA. 2. Tris-chelated complexes of cobalt (III) and iron (II) with 1, 10-phenanthroline and 2, 2'-bipyridine. J Am Chem Soc 111:8901-8911. doi:10.1021/ja00206a020
4. Chaires JB, Dattagupta N, Crothers DM 1982 Studies on interaction of anthracycline antibiotics and deoxyribonucleic acid: equilibrium binding studies on the interaction of daunomycin with deoxyribonucleic acid. Biochemistry 21:3933-3940. doi:10.1021/bi00260a005 (Pubitemid 13237187)
5. 2+. J Mol Struct 881:156-166. doi: 10.1016/j.molstruc.2007.09.010 (Pubitemid 351689007)
6. Cheng CC, Rokita SE, Burrows CJ 1993 Nickel (III)-promoted DNA cleavage with ambient dioxygen. Angew Chem Int Ed Engl 32:277-278. doi:10.1002/anie. 199302771
7. Cocchietto M, Sava G 2000 Blood concentration and toxicity of the antimetastasis agent NAMI-A following repeated intravenous treatment in mice. Pharmacol Toxicol 87:193-197. doi:10.1191/1078155204jp118oa
8. Cohen G, Eisenberg H 1969 Viscosity and sedimentation study of sonicated DNA-proflavine complexes. Biopolymers 8:45-49. doi:10.1002/bip. 1969.360080105
9. Collin JP, Sauvage JP 1986 Synthesis and study of mononuclear ruthenium (II) complexes of sterically hindering diimine chelates. Implications for the catalytic oxidation of water to molecular oxygen. Inorg Chem 25:135-141. doi:10.1021/ic00222a008
10. Dougan SJP, Sadler PJ 2007 The design of organometallic ruthenium arene anticancer agents. Chimia 61:704-715. doi:10.2533/chimia.2007.704
11. Dyson PJ 2007 Systematic design of a targeted organometallic antitumour drug in pre-clinical development. Chimia 61:698-703. doi:10.2533/chimia.2007.698
12. Erkkila KE, Odom DT, Barton JK 1999 Recognition and reaction of metallointercalators with DNA. Chem Rev 99:2777-2796. doi:10.1021/cr9804341
13. 2+. J Am Chem Soc 112:4960-4962. doi:10.1021/ja00168a052 (Pubitemid 20285921)
14. Gao F, Chao H, Wang JQ, Yuan YX, Sun B, Wei YF, Peng B, Ji LN 2007 Targeting topoisomerase II with the chiral DNA-intercalating ruthenium (II) polypyridyl complexes. J Biol Inorg Chem 12:1015-1027. doi:10.1007/s00775-007- 0272-4 (Pubitemid 47353546)
15. Ghosh A, Mandoli A, Kumar DK, Yadav NS, Ghosh T, Jha B, Thomas JA, Das A 2009 DNA binding and cleavage properties of a newly synthesised Ru (II)-polypyridyl complex. Dalton Trans 42:9312-9321. doi:10.1039/b906756f
16. Habtemariam A, Melchart M, Fernandez R, Parsons S, Oswald IDH, Parkin A, Fabbiani FPA, Davidson JE, Dawson A, Aird RE, Jodrell DI, Salder PJ 2006 Structure-activity relationships for cytotoxic ruthenium (II) arene complexes containing N, N-, N, O-, and O, O-chelating ligands. J Med Chem 49:6858-6868. doi:10.1021/jm060596m (Pubitemid 44749753)
17. Hartinger CG, Zorbas-Seifried S, Jakupec MA, Zorbas H, Kepper BK 2006 From bench to bedside-preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis (1H-indazole) ruthenate (III)] (KP1019 or FFC14A). J Inorg Biochem 100:891-904. doi: 10.1016/j.jinorgbio.2006. 02.013 (Pubitemid 44308176)
18. 2]. J Biol Inorg Chem 9:354-364. doi: 10.1007/s00775-004-0531-6 (Pubitemid 38595920)
19. Huang HL, Tang GP, Wang QQ, Li D, Shen FP, Zhou J, Yu H 2006 Two novel non-viral gene delivery vectors: low molecular weight polyethylenimine cross-linked by (2-hydroxypropyl)-b-cyclodextrin or (2-hydroxypropyl)- ccyclodextrin. Chem Commun 22:2382-2384. doi:10.1039/b601130f (Pubitemid 43846385)
20. Lesko SA, Lorentzen RJ, Ts'o PO 1980 Role of superoxide in deoxyribonucleic acid strand scission. Biochemistry 19:3023-3028. doi:10.1021/bi00554a029
21. Li TR, Yang ZY, Wang BD, Qin DD 2008 Synthesis, characterization, antioxidant activity and DNA-binding studies of two rare earth (III) complexes with naringenin-2-hydroxy benzoyl hydrazone ligand. Eur J Med Chem 43:1688-1695. doi:10.1016/j.ejmech.2007.10.006
22. Liu YJ, Chao H, Yuan YX, Yu HJ, Ji LN 2006 Ruthenium (II) mixed-ligand complexes containing 2-(6-methyl-3-chromonyl) imidazo[4, 5-f][1, 10]-phenanthroline: synthesis, DNA-binding and photocleavage studies. Inorg Chim Acta 359:3807-3814. doi:10.1016/j.ica.2006.05.015
23. Liu J, Zheng WJ, Shi S, Tan CP, Chen JC, Zheng KC, Ji LN 2008 Synthesis, antitumor activity and structure-activity relationships of a series of Ru (II) complexes. J Inorg Biochem 102:193-202. doi:10.1016/j.jinorgbio.2007.07.035
24. Liu YJ, Zeng CH, Wu FH, Yao JH, He LX, Huang HL 2009 Synthesis, characterization, photocleavage of DNA and cytotoxicity of ruthenium (II) mixed-ligand complexes. J Mol Struct 932:105-111. doi:10.1016/j.molstruc.2009. 05.046
25. Liu YJ, Zeng CH, Huang HL, He LX, Wu FH 2010 Synthesis, DNA-binding, photocleavage, cytotoxicity and antioxidant activity of ruthenium (II) polypyridyl complexes. Eur J Med Chem 45:564-571. doi:10.1016/j.ejmech.2009.10. 043
26. Melchart M, Sadler PJ (2006) In: G. Jaouen (ed) Bioorganometallics: biomolecules, labeling, medicine. Wiley-VCH, Weinheim, pp 39-64
27. Metcalfe C, Thomas JA 2003 Kinetically inert transition metal complexes that reversibly bind to DNA. Chem Soc Rev 32:215-224. doi:10.1039/b201945k
28. Mosmann TJ 1983 Utilization of purified human monocytes in the agarose droplet assay for measuring migration inhibitory factors. Immunol Methods 65:55-63. doi: 10.1016/0022-1759 (83) 90302-2
29. Nilsson R, Merkel PB, Kearns DB 1972 Unambiguous evidence for the participation of singlet oxygen (1) in photodynamic oxidation of amino acids. Photochem Photobiol 16:117-124. doi:10.1111/j.1751-1097.1972. tb07343.x
30. Reedijk J 2003 Bioinorganic chemistry special feature: new clues for platinum antitumor chemistry: kinetically controlled metal binding to DNA. Proc Natl Acad Sci USA 100:3611-3616
31. Reichmann MF, Rice SA, Thomas CA, Doty P 1954 A further examination of the molecular weight and size of desoxypentose nucleic acid. J Am Chem Soc 76:3047-3053. doi:10.1021/ja01640a067
32. Sarkar T, Petrov AS, Vitko JR, Santai CT, Harvey SC, Mukerji I, Hud NV 2009 Integration host factor (IHF) dictates the structure of polyamine-DNA condensates: implications for the role of IHF in the compaction of bacterial chromatin. Biochemistry 48:667-675. doi:10.1021/bi8019965
33. Satyanarayana S, Dabrowiak JC, Chaires JB 1993 Tris (phenanthroline) ruthenium (II) enantiomer interactions with DNA: mode and specificity of binding. Biochemistry 32:2573. doi:10.1021/bi00061a015
34. 2CS, n = 2]. Eur J Inorg Chem 19:3034-3046. doi:10.1002/ejic.200700206
35. 2 with N-N = bpy, phen, dpq, dppz, and dppn. Chem Med Chem 3:1104-1109. doi:10.1002/cmdc.200800039
36. Spector DL, Goldman RD, Leinwand LA (1998) In cells: a laboratory manual, vol 1. Cold Spring Harbor Laboratory Press, New York, chap 15
37. Steck EA, Day AR 1943 Reactions of phenanthraquinone and retenequinone with aldehydes and ammonium acetate in acetic acid solution. J Am Chem Soc 65:452-456. doi: 10.1021/ja01243a043
38. Sullivan BP, Salmon DJ, Meyer TJ 1978 Mixed phosphine 2, 2'-bipyridine complexes of ruthenium. Inorg Chem 17:3334-3341. doi:10.1021/ic50190a006
39. 2+. Inorg Chem 48:4637-4639. doi:10.1021/ic900102r
40. Tan CP, Liu J, Chen LM, Shi S, Ji LN 2008 Synthesis, structural characteristics, DNA binding properties and cytotoxicity studies of a series of Ru (III) complexes. J Inorg Biochem 102:1644-1653. doi:10.1016/j.jinorgbio.2008. 07.005
41. Tan LF, Liang XL, Liu XH 2009 Synthesis, double stranded DNA-binding and photocleavage studies of a functionalized ruthenium (II) complex with 7, 7'-methylenedioxyphenyldipyrido[3, 2-a:2', 3'-c]-phenazine. J Inorg Biochem 103:441-447. doi:10.1016/j.jinorgbio.2008.12.010
42. Velders AH, Kooijman H, Spek AL, Haasnoot JG, de Vos D, Reedijk J 2000 Strong differences in the in vitro cytotoxicity of three isomeric dichlorobis (2-phenylazopyridine) ruthenium (II) complexes. Inorg Chem 39:2966-2967. doi:10.1021/ic000167t
43. Vijayanathan V, Thomas T, Shirahata A, Thomas TJ 2001 DNA condensation by polyamines: a laser light scattering study of structural effects. Biochemistry 40:13644-13651. doi:10.1021/bi010993t (Pubitemid 33130792)
44. Vilaplana RA, González-Vilchez F, Gutiérrez-Puebla E, Ruiz-Valero C 1994 The first isolated antineoplastic Ru (IV) complex: synthesis and structure of [Cl2 (1, 2-cyclohexanediaminotetra acetate) Ru]-2H2O. Inorg Chim Acta 224:15-18. doi:10.1016/0020-1693 (94) 04159-8
45. Vilaplana RA, Delmani F, Manteca C, Torreblanca J, Moreno J, García-Herdugo G, González-Vilchez FJ 2006 Synthesis, interaction with double-helical DNA and biological activity of the water soluble complex cis-dichloro-1, 2-propylenediamine-N, N, N', N'-tetraacetato ruthenium (III). J Inorg Biochem 100:1834-1841. doi:10.1016/j.jinorgbio. 2006.07.012
46. Waring MJ 1965 Complex formation between ethidium bromide and nucleic acids. J Mol Biol 13:269-281. doi: 10.1016/S0022-2836 (65) 80096-1
47. Wu JZ, Ye BH, Wang L, Ji LN, Zhou JY, Li RH, Zhou ZY 1997 Bis (2, 2'-bipyridine) ruthenium (II) complexes with imidazo[4, 5-f][1, 10]-phenanthroline or 2-phenylimidazo [4, 5-f][1, 10]phenanthroline. Dalton Trans 8:1395-1401. doi: 10.1039/a605269j
48. Xu H, Zheng KC, Lin LJ, Li H, Gao Y, Ji LN 2004 Effects of the substitution positions of Br group in intercalative ligand on the DNA-binding behaviors of Ru (II) polypyridyl complexes. J Inorg Biochem 98:87-97. doi: 10.1016/j.jinorgbio.2003.09.002 (Pubitemid 37495014)
49. Yan YK, Melchart M, Habtemariam A, Sadler PJ 2005 Organometallic chemistry, biology and medicine: ruthenium arene anticancer complexes. Chem Commun 38:4764-4776. doi:10.1039/b508531b (Pubitemid 41509143)
50. 2+. J Inorg Biochem 103:881-890. doi: 10.1016/j.jinorgbio. 2009.03.005
51. Zeglis BM, Pierre VC, Barton JK 2007 Metallo-intercalators and metallo-insertors. Chem Commun 4565-4579. doi: 10.1039/b710949k (Pubitemid 350077044)
52. Zorzet S, Sorce A, Casarsa C, Cocchietto M, Sava G 2001 Pharmacological effects of the ruthenium complex NAMI-A given orally to CBA mice with MCa mammary carcinoma. Met Based Drugs 8:1-7. doi: 10.1155/MBD.2001.1